Abeona Therapeutics, Inc.
| Public | |
| Traded as | NASDAQ: ABEO |
| ISIN | 🆔 |
| Industry | Biomedicine |
| Founded 📆 | Dallas, Texas 1989 |
| Founder 👔 | |
| Headquarters 🏙️ | , |
Area served 🗺️ | |
| Members | |
Number of employees | |
| 🌐 Website | http://abeonatherapeutics.com/ |
| 📇 Address | |
| 📞 telephone | |
Abeona Therapeutics, Inc. is a pharmaceutical development company. Its research focuses on developing treatments for rare diseases using gene therapy and human plasma-derived therapeutics. The company is trying to find ways to address Sanfilippo Syndrome, Fanconi anemia, and Juvenile Batten disease.[1] It has stated it anticipates starting clinical trials on an adeno-associated virus-based gene therapy for Sanfilippo syndrome in 2015.[2]
Abeona also is developing a salt diafiltration process for purifying proteins from blood plasma[3] and a polymer hydrogel for delivering drugs.
Name changes[edit]
The company was formerly known as Access Pharmaceuticals. It was based in Dallas and was incorporated in 1989.[4] In 2014, the company changed its name to PlasmaTech Biopharmaceuticals. In 2015, PlasmaTech acquired a company based in Cleveland called Abeona Therapeutics which was founded in 2013.[5] In June 2015, the parent company adopted the name Abeona Therapeutics.[6]
The name Abeona comes from the Roman goddess Abeona, who was said to protect children.[7] The company's stock is traded on NASDAQ under the symbol ABEO.
References[edit]
- ↑ "Research & Development". Abeona Therapeutics. 2014-06-20. Retrieved 2015-09-20.
- ↑ PlasmaTech Biopharmaceuticals May 6, 2015 6:03 AM (2015-05-06). "PlasmaTech Biopharmaceuticals Announces Agreement to Acquire Abeona Therapeutics LLC - Yahoo Finance". Finance.yahoo.com. Retrieved 2015-09-20.
- ↑ "Abeona Therapeutics Provides Update on SDF(TM) (Salt Diafiltration) Plasma Fractionation Products". MarketWatch. 2015-07-07. Retrieved 2015-09-20.
- ↑ "ABEO - Company Profile for Abeona Therapeutics Inc - MSN Money". Msn.com. 2015-07-31. Retrieved 2015-09-20.
- ↑ "George Soros-backed PlasmaTech to acquire Cleveland's Abeona Therapeutics". Dallas Business Journal. 6 May 2015. Retrieved 21 September 2015.
- ↑ "PlasmaTech gets $8.5M infusion from investors George Soros, Perceptive Advisors, changes name to Abeona Therapeutics - Dallas Business Journal". Dallas Business Journal. 29 July 2015. Retrieved 21 September 2015.
- ↑ "Press Release | Investors | Abeona Therapeutics". Investors.abeonatherapeutics.com. 2014-06-20. Retrieved 2015-09-20.
External links[edit]
This article "Abeona Therapeutics" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
